Antithrombotic activity of flavonoids and polyphenols rich plant species

Area of Science:

• Pharmacology and Phytochemistry
• Cardiovascular Research
• Natural Product Chemistry

Background:

• Cardiovascular diseases (CVDs) pose a significant global health burden, with thrombus formation being a critical underlying factor in conditions like stroke and heart attack.
• Current prophylactic strategies, such as acetylsalicylic acid and clopidogrel, target primary hemostasis but are associated with costs and potential side effects.
• Rising healthcare expenditures for CVDs underscore the need for novel preventive approaches, highlighting interest in natural compounds.

Purpose of the Study:

• To review the anti-aggregatory effects of polyphenols, particularly flavonoids, on platelet aggregation.
• To examine the impact of plant extracts rich in polyphenols on platelet aggregation.
• To correlate the chemical composition and antioxidant properties of these plant-derived compounds with their observed biological effects and potential clinical significance.

Main Methods:

• Literature review focusing on studies investigating the anti-platelet activity of polyphenols and polyphenol-rich plant extracts.
• Analysis of research on the chemical constituents of selected medicinal plants known for their polyphenol content.
• Examination of studies linking antioxidant properties to the anti-aggregatory effects of these compounds.

Main Results:

• Polyphenols, especially flavonoids, demonstrate significant anti-platelet aggregation properties.
• Various plant extracts (e.g., propolis, Salvia sp., Lavandula angustifolia) rich in polyphenols exhibit inhibitory effects on platelet aggregation.
• A positive association exists between the polyphenol content, antioxidant capacity, and the observed anti-aggregatory efficacy of plant-derived compounds.

Conclusions:

• Polyphenols and polyphenol-rich plant extracts represent a promising area for the development of natural therapeutic agents for preventing thrombus formation.
• The anti-aggregatory effects of these compounds suggest potential clinical applications in managing and preventing cardiovascular events.
• Further research is warranted to elucidate specific mechanisms and confirm clinical efficacy for widespread application.